How to Reduce Medical Stock Expiry Waste

Why medical stock expires

Medicines and many medical products carry expiry dates and cannot be used past them. When short-dated stock is overlooked while longer-dated stock ships, the short-dated stock expires and is written off — an avoidable loss.

How to cut expiry waste

• FEFO rotation — always dispatch soonest-to-expire stock first.
• Expiry visibility — batch and expiry tracking so short-dated stock is known.
• Early action — flag and prioritise soon-to-expire stock before it becomes waste.
• Accurate counts — keep recorded and physical stock aligned.

How SFIMS helps

SFIMS applies FEFO picking backed by GS1 batch-and-expiry traceability and stock reporting, so short-dated stock is dispatched first and expiry waste is minimised.

Most waste is created at the order

Expiry loss is usually attributed to the warehouse and usually originates in purchasing. By the time stock is short-dated the decision that created the problem is months old.

The recurring causes are ordering to a supplier minimum rather than to demand, taking a volume discount that outlasts the shelf life it buys, over-ordering ahead of a tender that is not yet won, forecasting from a period that was not representative, and buying to a round number because the pack size is convenient.

Each is defensible individually. Together they explain the majority of write-offs, and none of them can be corrected downstream. The warehouse can only slow the loss, not prevent it.

The economics of the write-off decision

Short-dated stock forces a choice, and delaying it is the most expensive option.

Sell it early, even at a reduced margin. Almost always better than a total loss, and possible only if the stock was identified early enough to still have commercial life.

Return it to the supplier where the agreement allows, which is why return terms are worth negotiating before they are needed rather than after.

Redistribute it to a customer or region with faster turnover.

Write it off and destroy it under a documented process.

The value of the first three declines every week the decision is postponed, which is the strongest argument for reviewing expiry exposure monthly rather than quarterly.

Making expiry visible to the people who can act

Expiry data usually exists and usually sits where nobody who can act on it will see it.

The warehouse knows what is short-dated. Purchasing decides what to buy. Sales decides what to push. If the expiry report goes only to the warehouse, the only available response is to watch it happen.

A short monthly report, sent to all three, listing stock expiring within a defined horizon with its value and rate of sale, converts the problem into decisions somebody can actually take. It costs nothing and is the single most effective intervention available, because the constraint is rarely information — it is that the information is not reaching the person who can act.